Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens
Main Authors: | Reeve, J, Hesp, R, Audran, M, Renier, J, Slovik, D, Neert, R, Edouard, C, Meunier, P |
---|---|
Format: | Journal article |
Published: |
1986
|
Similar Items
-
The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
by: Hesp, R, et al.
Published: (1981) -
A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
by: Reeve, J, et al.
Published: (1986) -
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
by: Reeve, J, et al.
Published: (1991) -
Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
by: Reeve, J, et al.
Published: (1981) -
Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
by: Bradbeer, J, et al.
Published: (1992)